05.06.2024  22:10:00 Zm. +0,68 Wolumen Bid13:00:01 Ask13:00:01 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
289,10USD +0,24% 154 158
Obrót: 21,3 mln
265,80Wolumen Bid: 100 305,30Wolumen Ask: 100 6,78 mldUSD - -

Opis działalności

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations.
 

Zarząd & Rada nadzorcza

CEO
Norman Schwartz
Zarząd
Ilan Daskal, Ajit Ramalingam, Andrew Last, Dara Wright, Mike Crowley, Timothy S. Ernst, Simon May, Diane Dahowski
Rada nadzorcza
Norman Schwartz, Alice N. Schwartz, Arnold Pinkston, Gregory Hinckley, Jeffrey Edwards, Melinda Litherland
 

Dane firmy

Nazwa: Bio-Rad Laboratories Inc.
Adres: 1000 Alfred Nobel Drive,Hercules, California 94547, USA
Telefon: +1-510-741-7000
Fax: +1-510-741-5817
E-mail: -
Internet: www.bio-rad.com
Przemysł: Służba zdrowia
Sektor: Produkty Medyczne
Podsektor: Zaawansowane Urządzenia Medyczne
Koniec roku finansowego: 31.12
Free float: 70,50%
Data IPO: 03.03.1980

Relacje inwestorskie

Nazwa: Edward Chung
Telefon: +1-510-741-6104
Fax: -
E-mail: ir@bio-rad.com

Główni akcjonariusze

Inne
 
61,54%
Vanguard Group Inc
 
9,98%
Blackrock Inc.
 
6,57%
Veritas Asset Management LLP
 
4,74%
Brown Advisory Inc.
 
3,86%
State Street Corporation
 
3,75%
Ubs Asset Management Americas Inc
 
2,23%
Alliancebernstein L.P.
 
1,91%
Alliancebernstein L.P.
 
1,88%
Inne
 
3,54%